Cetuximab Rechallenge Study
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
To determine the objective overall response of re-treatment with cetuximab-based chemotherapy in patients upon disease progression while under observation, who had previously responded to first-line or second-line treatment with cetuximab-based chemotherapy for metastatic colorectal cancer (mCRC), but had stopped treatment for reasons other than disease progression.
创建时间：
2013-04-15
